v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 10,838 $ 29
Operating expenses    
Research and development 13,110 13,588
General and administrative 6,803 8,553
Total operating expenses 19,913 22,141
Operating loss (9,075) (22,112)
Other (expense) income:    
Gain from equity method investment 0 1,342
(Loss) gain on changes in other fair value adjustments (2,951) 49
Loss on change in fair value of warrant liability (7,107) (804)
Interest expense (311) (354)
Interest income 999 1,323
Gain (loss) on disposal of assets 4 (9)
Total other (expense) income (9,366) 1,547
Net loss $ (18,441) $ (20,565)
Net loss per share    
Basic (in USD per shares) $ (0.75) $ (2.21)
Diluted (in USD per shares) $ (0.75) $ (2.21)
Weighted-average shares of common stock outstanding    
Basic (in shares) 24,634,443 9,292,066
Diluted (in shares) 24,634,443 9,292,066